Professional Summary

Professional Overview

Ian Estepan is the Executive Vice President and Chief Financial Officer at Sarepta Therapeutics, a leading biotechnology company focused on developing innovative therapies for rare diseases. With over 20 years of experience in the financial and pharmaceutical industries, Estepan brings a wealth of expertise in strategic planning, corporate finance, and operational leadership.

Experience Summary

Current Role

As the Executive Vice President and Chief Financial Officer at Sarepta Therapeutics, Estepan is responsible for overseeing the company's financial strategy, reporting, and control functions. He plays a crucial role in driving the company's growth and ensuring its long-term financial stability. Estepan's leadership has been instrumental in securing significant funding and strategic partnerships to support Sarepta's pipeline of groundbreaking therapies.

Career Progression

Prior to his current role, Estepan served as the Senior Vice President, Chief of Staff and Corporate Affairs at Sarepta Therapeutics, where he was instrumental in streamlining operations and enhancing cross-functional collaboration. Before joining Sarepta, he held the position of Portfolio Manager at Spectra Financial Group, where he successfully managed a diversified investment portfolio. Estepan's early career experience includes roles as the Director of Strategic Planning at The MusicBooth LLC and a Financial Analyst at Salomon Smith Barney Holdings Inc.

Academic Background

Estepan holds a Bachelor of Science degree in Finance from the University of Massachusetts, where he graduated with honors.

Areas of Expertise

• Corporate finance and strategic planning

• Financial reporting and control systems

• Operational efficiency and process optimization

• Mergers, acquisitions, and strategic partnerships

• Investor relations and stakeholder management

Professional Impact

During his tenure at Sarepta Therapeutics, Estepan has played a pivotal role in securing over $1 billion in funding to support the company's research and development efforts. He has also led the successful integration of several strategic acquisitions, strengthening Sarepta's pipeline and expanding its reach in the rare disease treatment landscape.

Conclusion

With his extensive financial expertise, strategic vision, and proven track record of driving growth, Ian Estepan is a respected leader in the biotechnology industry. In his current role as the Executive Vice President and Chief Financial Officer at Sarepta Therapeutics, he continues to contribute to the company's mission of transforming the lives of patients with rare diseases.